Harbour Investments’s Ascendis Pharma A/S ASND Stock Holding History

Harbour Investments’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2K	Buy	38 +11	+41%	+$2.57K	﹤0.01%	3349
2026 Q1	$6.23K	Buy	+27	New	+$6.05K	﹤0.01%	3494
2021 Q4	–	Sell	-145	Closed	-$23K	–	2676
2021 Q3	$23K	Sell	145 -47	-24%	-$6.43K	﹤0.01%	2211
2021 Q2	$25K	Buy	+192	New	+$25.6K	﹤0.01%	2206

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Harbour Investments's ASND Position: Q2 2026 in Review

Harbour Investments increased its Ascendis Pharma A/S (ASND) stake by 41% in Q2 2026, buying an estimated $2.57K and bringing the position to 38 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

Harbour Investments first reported a position in ASND in Q2 2021 and has held it in 4 quarters since. The position peaked at $25K in Q2 2021. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Harbour Investments held 38 shares of Ascendis Pharma A/S worth $10.2K as of Q2 2026.
Harbour Investments bought 11 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.57K.
Ascendis Pharma A/S made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3349 holding.
Harbour Investments first reported a position in Ascendis Pharma A/S in Q2 2021 and has held it in 4 quarters since.
Harbour Investments's Ascendis Pharma A/S position peaked at $25K in Q2 2021.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.